Orphan Drug Forum 2014

3rd Annual Orphan Drugs Forum
working with patients and regulatory bodies
the granting of orphan designations
austerity-conscious governments
the essential role of patients
cost-cutting pressure
a different approach
attractiveness


SPECIAL FEATURES:
STREAM A: Market Access, Pricing & Reimbursement and Financing
STREAM B: Clinical Development and R&D

KEY TOPICS
Discuss how to improve processes for designation and speed up approval processes
Find out National Authorities’ interpretation of orphan drugs legislation and its impact on drug development
Learn how to effectively prepare for commercialization within Europe, the US and beyond
Explore the relevance of Patient Registries in the development of clinical research
Exchange knowledge on how to maximize partnerships and alliances
Examine the essential role of patient organisations in promoting access to treatment